About Kuano
Kuano is a company founded in 2020 by David Wright. It operates as a AI-as-a-Service. Kuano has raised $3.63 million across 2 funding rounds from investors including Mercia, ACF Investors and Ascension Ventures. The company has 4 employees as of March 31, 2022. Kuano offers products and services including Quantum Simulation & AI Solutions. Kuano operates in a competitive market with competitors including Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others.
- Employees 4 as on 31 Mar, 2022
- Founders David Wright
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kuano Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.63 M (USD)
in 2 rounds
-
Latest Funding Round
$2.25 M (USD), Seed
Sep 12, 2023
-
Investors
Mercia
& 4 more
-
Employee Count
4
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kuano
Kuano offers a comprehensive portfolio of products and services, including Quantum Simulation & AI Solutions.
Solutions for drug design using quantum and AI technology.
People of Kuano
Unlock access to complete
Unlock access to complete
Funding Insights of Kuano
Kuano has successfully raised a total of $3.63M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $2.25 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Kuano
Kuano has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Mercia, ACF Investors and Ascension Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on angel investments
|
Locked | Locked | Locked | |
|
Strategic investments in healthcare technologies and data innovations.
|
Locked | Locked | Locked | |
|
Investment management services are provided by Mercia to various clients.
|
Locked | Locked | Locked |
Investor details for Kuano
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kuano
Investment portfolio details for Kuano
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kuano
Detailed financials for Kuano
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kuano Comparisons
Peer comparison for Kuano
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kuano
Kuano operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An agentic AI platform is developed for biomedical research insights.
|
|
| Locked | Locked | Locked |
AI-powered drug discovery platform for various diseases
|
|
| Locked | Locked | Locked |
AI-based technology is used for recombinant protein production in therapeutics.
|
|
| Locked | Locked | Locked |
Antibody therapies are developed through machine learning and synthetic biology.
|
|
| Locked | Locked | Locked |
AI-based platform for cancer diagnostics and precision medicine is utilized.
|
|
| Locked | Locked | Locked |
AI platform used for extracting antibody data from scientific papers.
|
Detailed competitors of Kuano
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kuano
Complete news archive for Kuano
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kuano
Kuano was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Kuano is a funded company, having raised a total of $3.63M across 2 funding rounds to date.
As of Mar 31, 2022, the latest employee count at Kuano is 4.
Kuano is engaged in developing quantum simulation and AI-driven solutions for drug design. The company operates in the biotechnology and pharmaceutical sectors, leveraging advanced technology to enhance drug discovery processes. Their expertise lies in combining quantum computation with artificial intelligence to address complex challenges in enzyme inhibition and drug development.
Kuano's top competitors include Owkin, Formation Bio and XtalPi.
Kuano offers Quantum Simulation & AI Solutions.
Kuano has 5 investors. Key investors include Mercia, ACF Investors, Ascension Ventures, o2h ventures, and Meltwind Advisory.